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This paper proposes that human prostate carcinoma primarily invades as a cohesive cell collective through a mechanism similar
to embryonic tubulogenesis, instead of the popular epithelial-mesenchymal transformation (EMT) model. Evidence supporting
a tubulogenesis model is presented, along with suggestions for additional research. Additionally, observations documenting
cell adhesion molecule changes in tissue and stromal components are reviewed, allowing for comparisons between the current
branching morphogenesis models and the tubulogenesis model. Finally, the implications of this model on prevailing views of
therapeutic and diagnostic strategies for aggressive prostatic disease are considered.
1.Introduction
Most pathologists recognize prostate cancer as a series
of polarized glandular structures lacking basal cells and
varying in diﬀerentiation from lumen forming tubules to
solid cords. These morphological observations are consistent
with an invasion model in which cohesive groups of cells
bud oﬀ from an in situ precursor lesion such as high-
grade prostate intraepithelial neoplasia (HGPIN). Recent
molecular marker expression studies are also consistent with
this view. However, a prevalent view of prostate cancer
invasion depicts single tumor cells invading the surrounding
stroma, preceding vascular intravasation and dissemination.
This widely held view of metastasis of epithelial cancers
involves an epithelial-mesenchymal transformation (EMT)
[1]. EMT of the malignant cells at the primary tumor allows
for a motile invasive single-cell phenotype [1–4].
EMT is associated with the loss of epithelial-speciﬁc E-
cadherin from the adheren junctions and a switch from the
expression of keratins as the major intermediate ﬁlament to
themesenchymal intermediate ﬁlament, vimentin [5].While
this concept may be formally possible in epithelial cancers, it
is rarely observed in prostate cancers except in the relatively
rare Gleason Grade 5 tumors. In fact, others have noted that
EMT in cancer invasion is not universally observed [6–8].
Additionally, some models state that, in the absence of EMT
inducing signals, tumor cells may also reverse the process
and undergo a mesenchymal to epithelial transition (MET)
[9, 10]. This transient nature is proposed to explain why
metastatic cells morphologically resemble primary tumor
cells. An alternative possibility is that the cancer phenotype
does notchange and, therefore, requires no companionMET
process. We propose that human prostate cancer invasion
is an EMT-independent event. The invasive collective of
tumor cells remain epithelial in nature—and, therefore, do
not require a shift back to the epithelial phenotype. This
review will challenge the applicability of the EMT concept
for prostate cancer and oﬀer an alternative idea: primary
prostate cancers invade by a process similar to embryonic
tubulogenesis.
2.Prostate CancerMorphology
A modiﬁed grading system based upon Gleason scoring
is used to describe prostate cancer morphology [11]. The
majority of low Gleason Grade lesions and even Gleason2 Prostate Cancer
Grade 4 lesions arise from high-grade prostatic intraepithe-
lial neoplasia (PIN) lesions and appear as invasive tubular
structures (Figure 1).
Invasive tubular structures persist in lymph node meta-
static lesions, as judged by prominent E-cadherin expression
[12, 13], suggesting that prostate carcinoma invades by
collective cell migration (see Friedl and Gilmour [14]), a
process analogous to normal tubulogenesis. In embryologic
tubulogenesis, coherent cells inﬂuenced by stromal factors
initially migrate into the surrounding stroma as solid cords
of cells. Later, lumina are formed and the cells develop
polarity with their luminal surfaces facing a lumen and
with their basal surfaces resting on a basal lamina [15]. In
simple Grade 3 lesions, the polarity is complete. In cribiform
Grade 3 and 4 lesions, the polarity is deranged with multiple
lumina. In Grade 4, there is solid cord-like lesions form
that lacksany lumina. The normal morphological alterations
and modiﬁcations of the prostate gland yield important
clues to the molecular events involved in the deregulation of
the gland during cancer progression. In particular, prostate
cancer tubulogenesis occurs in areas where the basal cells are
lost and the basal lamina lacks laminin 332 (Figure 1).
2.1. The Relationship of Prostate Glands to the Surround-
ing Stroma. The prostate gland, under the inﬂuence of
androgen, develops from the endoderm-derived urogenital
sinus to form branched tubuloalveolar glands [16]. These
normal prostate glands are composed of two cell types, the
b a s a lc e l la n dt h es e c r e t o r yl u m i n a lc e l l s[ 16]. The normal
glands are surrounded by a delicate basal lamina containing
laminins 111/121, 211, 332, and 511/521, as well as collagen
IV and collagen VII [17]. The basal cells attach to this
substratum through a number of integrins: α2, α3, α4, α5,
α6, coupled with β1a n dαvβ3[ 18]. A dominant attachment
occurs through hemidesmosomes via the α6β4 integrin, an
essential gene product, interacting at the c-terminal ends
withanchoring ﬁlaments(laminin332)that,inturn,interact
with anchoring ﬁbers (Collagen VII) [19]. Loss of the
α6β4 integrin function in normal epithelial tissues results
in blistering diseases, indicating its essential role [20]. The
architecture and assembly of ECM molecules in embryonic
spaces provides a morphogenetic language or code that can
promote or restrict cell movements and determine cell fate
[21, 22]. In human prostate cancer, loss of α6β4i n t e g r i n
and type VII collagen is a universal feature [13, 18, 19,
23, 24]. In preclinical models, normal prostate cells have
a robust DNA damage response dependent upon laminin
[25]; early loss of the laminin receptor, α6β4 expression,
promotes tumor progression [26]. In the model proposed
here, the documented loss of a dominant adhesion structure
ispermissive forthe cohesive buddingof cell clustersinto the
stroma.
The luminal cells are thought to arise from stem-type
cells within the basal cell population [27]. The luminal
cells are primarily secretory, express androgen receptors, and
produce the proteins of the seminal ﬂuid, including prostate
speciﬁc androgen (PSA). Mitotic errors during intermediate
stages of luminal cell development have been postulated as a
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Figure 1: Tubulogenesis model of prostate cancer invasion. High-
grade prostatic intraepithelial neoplasia (PIN) gives rise to various
degrees of polarity and diﬀerentiation of cellular buds. PIN lesions
are glandular-type structures characterized by gaps of laminin 10
(brown bar, laminin 10 (511)) and sporadic retention of basal
cells (blue) attached to a laminin 5 matrix (laminin 5, 332). Three
diﬀerent patterns of spread (arrows) arise from PIN lesions. Note
complete polarity and lumen formation (grade 3), partial lumen
formation in cribiform lesion (grades 3-4 depending on size) and
lack of lumen formation (grade 5). Importantly, budding occurs in
areas where basal cells are lost, and the basal lamina lacks laminin5
(332); the invasive budding clusters of cells are exposed to laminin
10 (511).
possible origin for human prostate cancer [28]. In addition,
recent work has indicated that luminal cells as compared to
basal cells appear defective in their ability to invoke a DNA
damage response [29].
Taken together, these observations suggest that loss of
a dominant adhesion structure permits budding of cell
clusters that are more susceptible to ﬁxed DNA damage. In
this context, we note that an accumulation of ﬁxed DNA
damage has been previously reported in human prostate
cancer tissue [30]. Further, the loss of the normal glandular
structure and the loss of fundamental positional cues would
provide extracellular signals for invasive budding within a
new environment, rich in laminin 511, an essential molecule
in development that determines cell fate.
2.2.ChangesduringProstateCancerProgression. InPIN(pro-
static intraepithelial neoplasia) lesions, cells with enlarged
nuclei and often prominent nucleoli proliferate within the
lumen, enlarging the glands and eventually causing the
basal cell layer to become attenuated, resulting in continuity
gaps. Interestingly, where the basal cells persist, the integrin
expression and the hemidesmosomes also persist, including
the underlying basal lamina that expresses laminin 332 [31].
In the gaps where the basal cells are lost, laminin 332 and
the protein elements of the hemidesmosome are missing
[18, 19, 23, 24]. The cells in these gap areas are attached inProstate Cancer 3
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Figure 2: High grade PIN lesion showing budding invasive
structure. PIN lesion (HGPIN) progressively changes into proximal
lumen formation (arrows) and a distal solid cord of tumor cells.
Normal prostate gland (N) is shown for comparison.H&E X400.
the gland via integrins α6β1a n dα3β1[ 32]a n da r er e a c t i v e
with an underlying basal lamina expressing laminin 511,
a laminin important for epithelial tubulogenesis [33, 34]
but not laminin 332. The cells making up the PIN lesions
express a mixture of basal cell and luminal cell proteins,
further suggesting origination in faulty mitosis [28]o r
defective DNA damage repair [29]. Analysis of a variety of
morphologicnuclearfeaturesshowed thatthese cellsarevery
similar to invasive carcinoma cells and are already showing
signs of genetic instability with a rate of aneuploidy similar
to invasive carcinoma [35, 36].
Recent studies have shown that approximately 16% of
PIN lesions show the rearrangement of the ETS-related
gene (ERG) [37, 38]. TMPRSS-ERG (transmembrane serine
protease) gene fusions are associated with the loss of α6β4
integrin expression, theknown regulatorofhemidesmosome
assembly. Numerous studies have associated early invasive
carcinoma with these PIN lesions [27, 39–42]. Others have
shown a discrepancy between the occurrence of high-grade
PIN (HGPIN) and carcinoma, suggesting that HGPIN is not
a precursor to invasive carcinoma [43, 44]. However, serial
sectioning of HGPIN reveals invasive tubular structures
arising from the PIN lesions (Figure 2,a r r o w s ) .
The invasive cell clusters arise from gap regions that lack
basal cells. The early detection of an invasive cell cluster
is observed as a budding of atypical cells into the stroma
(Figure 3). Of particular note is the lack of basal cells
within the lesion (Figure 3, arrows) which corresponds to
the known loss of dominant adhesion structures. As stated
earlier, theinvasive cellshavelosthemidesmosomes and have
ar e s t r i c t e dα6β1, α3β1 integrin expression [19].
The lack of basal cells in the budding cancer clusters
is conﬁrmed by a loss of cytokeratin 5 and 14 expression
(basal cell markers) and the corresponding loss laminin 332
(laminin 5) expression in the basal lamina, as observed in
serial sections shown in Figure 4. Of particular interest is
that while laminin 332 expression is lost in the budding
lesion, another form of laminin, laminin 511 (laminin10), is
abundant in the microenvironment, surrounding the glands
vessels and prominently expressed in the stroma (Figure 4).
Laminin 511 (LAM 10) is a potent morphogen essential for
embryonic development and governs cell fate [34]. As stated
earlier, invasive cancers express α6β1a n dα3β1, laminin 511
binding integrins.
Further studies utilizing in situ hybridization techniques
have shown that all three of the mRNAs encoding the three
laminin 332 chains are present and have normal sequences,
a ﬁnding that suggests the loss of protein expression is
controlled at the translational level [24, 45]. These cells are
polarized and have intact tight junctions as well as intact
zonula adherens [46, 47]. In less diﬀerentiated grades, they
may form cribiform glandular structures or solid trabecular
structures lacking lumens.
2.3. Relationship of Prostate Cancer Invasion to Tubulogenesis.
These early invasive events in which proliferating groups
of cells maintain cellular adhesion and reestablish tubu-
lar structures closely resemble embryologic tubulogenesis.
Knowledge of collective cellular migration (reviewed in
Friedl and Gilmour [14]) is derived from several areas of
embryology including the study of border cell migration in
Drosophila oogenesis [48], tracheal branching morphogen-
esis in insects [49, 50], mammary gland development [51,
52], and lateral line organogenesis in zebra ﬁsh [53]. From
studiesintheseandothersystems, aconceptoftubulogenesis
has arisen in which a placode of cells in an originating
epitheliumgivesrise locally to cells thatmigrate as a cohesive
mass in response to promigratory and polarity-preserving
signals produced by neighboring stromal cells. In order
for these events to occur, there must be cell-cell cohesion,
maintenance of polarity, cytoskeleton reorganization and
force generation, extracellular matrix (ECM) remodeling,
and stromal signal generation.
Although these processes are not as clearly understood
in cancer as they are in normal embryogenesis, there is
accumulatingevidencethattheprocessincancerprogression
is similar. It is clear from immunohistochemical studies
that low-grade prostate carcinomas maintain cell cohesion
through components of the tight junction including Z01,
claudins and occludin (see Martin and Jiang [47]), zonula
adherens (E-cadherin, B-catenin, desmosomes) [46], as well
as gap junction proteins and apical adhesion molecules
such as CEACAM1 (carcinoembryonic antigen-related cell
adhesion molecule 1) [54].
The maintenance of cell polarity is variable, with well-
diﬀerentiated tumors forming basal-luminal polarity in the
absence of basal cells. For example, E-cadherin and B-
catenin are expressed in low-grade prostate adenocarci-
noma (Figure 5). E-cadherin expression results in survival
advantage for tumor cells [55, 56]. Speciﬁcally, E-cadherin
dampens cellular motility behavior by biasing the direction
of cell migration without aﬀecting the migration rate. The
results also demonstrated that there is cross-talk between
E-cadherin and integrin-based adhesion complexes [57].
Integrin alpha 6 expression in human prostate carcinoma is4 Prostate Cancer
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Figure 3: Progressive morphologicalfeatures of tubulogenesis in human prostate cancer. (a) is a tissue section stained with H&E X 200 and
showsthe transition of a normalprostate gland (N) to high-grade PIN (P) which has budded into invasive low-grade carcinoma (Ca).(b) is
a tissue section stained with H&E X 400 demonstrating a prostate gland showing an early bud (arrows) of atypical cells. Note the absence of
basal cells in the budding lesion.
associated with a migratory and invasive phenotype both in
vitro and in vivo [58]. Taken together, these results would
indicate that the preservation of E-cadherin and laminin-
binding integrin expression in prostate cancer tubulogenesis
could aid in the formation and direction of tubular growth.
Several reports have shown reduced expression of E-
cadherin and B-catenin with increasing Gleason grade [59–
61]. Murant et al. [59] made the interesting observation that
there was a reciprocal increase of B1 integrin as E-cadherin
decreased. Busch et al. [54] demonstrated that occludin, a
componentofthetightjunctions,wasexpressedinlow-grade
prostate tumor but, with polarity loss, was downregulated
in Gleason Grade 4 tumors and completely lost in Grade 5
tumors.
Tubulogenesis results in prostate cancer cells becoming
attached to a newly synthesized basal lamina. In less diﬀer-
entiated tumors, complex cribiform structures are formed
with multipleintraglandularlumina. The invasion processin
human prostate carcinogenesis is slow, and littleinformation
is available regarding changes in cytoskeleton proteins at
the leading edge of the invading tubular structure, although
these contractile proteins are known to be important in
normal tubulogenesis [15].
It is also clear thatthere must be initial ECM degradation
and regeneration of new basal lamina to support the tubular
structures. Studies of invading cells in liquid culture or 3D
gels demonstrate two surface metalloproteinase molecules,
MTIMMP and MMP2, which degrade the ECM along the
leading cells [61, 62]. Our own studies of invasion utilizing
an xenograft model of DU145 human prostate cells seeded
onto the murine diaphragm revealed tumor colonization
of the surface. Collective cell invasion was induced when
the tumor cells were permanently transfected to express
the metalloproteinase MMP7 [63]. The murine diaphragm
surface mimics the stroma of the prostate and contains a
vascular supply, sensory and motor nerve endings, stromal
ﬁbroblasts, and muscle cells, making it a useful model
environment [64].All ofthese cell typesare potential sources
of stimulatory factors.
Invasion oforalsquamouscell carcinomain vitro report-
edly has been stimulated by paracrine SDF1 and hepatocyte
growth factor produced by stromal ﬁbroblasts driven by
tumor cell-derived cytokines [65]. There is an extensive
literature describing the role of hepatocyte growth factor
(HGF) and its receptor c-Met in prostate cancer progression
(see Hurle et al. [66]). Interaction of HGF with its receptor
has beendemonstrated to modulate cell proliferation, tumor
cell interaction, cell migration, cell-matrix adhesion, cell
invasion, and angiogenesisin prostate cancercells(Figure 6).
Other factors such as FGF and TGF-b have been also
implicated in the stimulation of tumor cell invasion [3, 67].
Another signaling factor known to be important in
normal embryonic epithelial modeling is the Wnt pathway,
which is involved in cell fate speciﬁcation, proliferation,
polarity, and migration [68]. Both the classic pathways—
involving a variety of Wnt ligands binding to the Frizzle
receptor and resulting in β-catenin transcription—and the
non-Canonicalpathway[68]demonstrateactivityinprostate
cancer (see Yardy and Brewster [69]). Studies have shown
that β-catenin interacts with the androgen receptor, perhaps
further indicatingitsrelevancetoprostatecancerprogression
[70].
Cells that eventually intravasate into vessels, it seems,
leave the active tips of the tubular invasive structures. Single-
cell migration into vessels would represent a form of EMT,
a possible late event in tubulogenesis, but this needs more
detailed documentation and validation. Moreover, there is
some evidence that even these intravascular cells retain
cohesive properties and actually travel as small groups of
attached cells [14]. A careful analysis of changes occurring
at the tips of these tubular structures is likely to produce
important information that may become the cornerstone
of new diagnostic and therapeutic treatments aimed at
preventing prostate carcinoma metastasis.Prostate Cancer 5
LAM5
(a)
CK5-14
(b)
LAM10
(c)
CK5-14
(d)
Figure 4: Budding lesions are devoid of basal cells and lack laminin 5 deposition and become exposed to laminin 10. Serial sections
containing cell clusters (white arrows) were stained either for laminin 332 (LAM5) or laminin 511 (LAM10) and the basal cell-speciﬁc
marker, cytokeratin 5 and 14 (CK5-14).
There is considerable evidence that nerves within the
peripheral zone in proximity to prostate cancer facilitate
tumor penetration of the capsule [67, 71]. Perineural
prostate carcinoma growth is routinely observed in areas
of extra prostatic extension, where these carcinomas can
maintain polarity (Figure 7) and have been observed lining
up along the basement membrane.
Invasive cancer invading stroma and then traveling along
neural structures has been observed in pancreatic cancer,
using serial sectioning methods to reveal tumors growing in
a continuous fashion [72]. While similar studies have not
been published describing this event in prostate cancer, we
infer that tubular structures of invading prostate carcinoma
would encounter nerve structures and then travel along
these conduits ﬁnally reaching the para-prostatic connective
tissue [73]. It is not clear at what juncture these cells
would intravasate into vascular structures, but it is clear that
perineural prostate cellsare notwithin vessel lumens, despite
growing in close proximity to lymphatic vessels.
2.4. Implications of theTubulogenesis Model of Prostate Cancer
Progression. There is a pressing need for biomarkers that
distinguish indolent from aggressive prostate cancer. It is
estimated that 30 to 50% of men diagnosed with prostate
cancer could avoid surgery or radiation (and instead be
followed by active surveillance) because they have “good
prognosis” tumorsthatare unlikelytoprogress[74].Further,6 Prostate Cancer
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Figure 5: Preservationof epithelial marker expression in invasiveprostate carcinoma.Serial sections of GleasonGrade 3 prostate carcinoma
reacted in (a) with anti-B-catenin and (b) reacted with anti-E-cadherin. Note maintenance of intracellular adhesionand polarity in invasive
carcinoma. X 200.
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Figure 6: Increased expression of a morphogenic growth factor and receptor in invasive budding cancer. Serial sections of Gleason Grade 3
prostatic carcinoma and normal gland (N) reacted in (a) with anti-c-Met (aka Hepatocyte Growth Factor (HGF) receptor) and (b) reacted
with anti-HGF. X 400.
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N
Figure7:Invasiveperineuralprostatecancermaintainscellpolarity
and intracellular adherence. Tissue section of prostate carcinoma
reacted with anti E-Cadherin antibody and surrounding a nerve
(N). X 400.
recent reports indicate that approximately 50% of patients
that are classiﬁed as high risk do not develop metastases
and 10% of patients classiﬁed as low risk develop secondary
disease [75]. The critical need for biomarkers has led to
integrative genomic proﬁling of human prostate cancer to
annotate alterations corresponding to clusters of low- and
high-risk disease beyond that achieved by the Gleason Score
[76].
Taylor et al. [76], in a hallmark study, combined meth-
ods of pathologist-guided dissection with comprehensive
genomic analysis and clinical outcome data. Transcriptomes
were deﬁned and copy number alterations documented in
218 prostate tumors (181 primaries and 37 metastases).
Several known cancer pathways were observed in human
prostate cancer, and the study revealed that nearly all metas-
tases contained changes in P13K, RAS/RAF, and androgen
receptor pathways. Independent work examining tumor
cells within bone marrow revealed a loss of cell adhesionProstate Cancer 7
components in disseminated tumor cells as a potential har-
binger of aggressive disease [75].
Extending the primary tumor analysis approach to
understanding the signatures of invasive budding tumors,
rather than analysis of the entire cancer specimen, would
likely reveal aggressive subsets of tumors. Prostate cancer is
multifocal, and intratumor genomic heterogeneity is a well-
knownphenomenon[77].Restricting analysis totheinvasive
tips of the tumor may clarify the relevance of the molecular
signatures for identifying aggressive disease. The inherent
diﬃculty in distinguishing the budding cancer from the
tumor epicenter will require developing improved strategies
of tissue analysis. Recent studies have used a strategy of
multiplexed quantum dot mapping to begin providing
correlated molecular and morphological information [78].
In other studies, terminal end buds (TEB) during mammary
branching morphogenesis have been microdissected, and
the transcriptomes identiﬁed; speciﬁc gene signatures are
associated with TEB [79]. A similar strategy couldbe utilized
todeﬁnebuddingprostatecancerfromthebulkofthetumor.
In a similar fashion, the responsiveness of the tumor
to therapeutic approaches, such as radiation therapy, may
be dictated by the degree to which tubulogenesis has been
activated. It is well known that the bulk of prostate cancer
is relatively radiation resistant as compared to other tumor
types. As a slow growing tumor, it is generally consid-
ered a tumor type that can be successfully treated using
hypofractionation at fractional doses up to 2.8Gy, since
tumor repopulation is not a factor [80]. Other groups are
testing whether hypofractionated stereotactic body radiation
therapy (19.5Gy in 3 fractions) followed by intensity-
modulated radiation therapy (IMRT) (dose of 50.4Gy in 28
fractions) oﬀers radiobiological beneﬁts of a large fraction
boost for dose escalation. The goal is to achieve a well-
tolerated treatment option for men with intermediate- to
high-risk prostate cancer [81]. Understanding the biological
responsivenessofinvasivebuddingtumorcellsandtheextent
of their activation as compared to the bulk of the tumor are
likely to increase the biological eﬀectiveness of the therapy
and limit normal tissue damage.
Preclinical xenograft and tissue culture studies revealed
the phenomenon of cell adhesion-mediated radiation resis-
tance (CAM-RR) [82–90]. CAM-RR can be overcome by the
loss of tumor cell adhesion to the extracellular matrix [25,
86, 90, 91].Sincethe tubulogenesismodel ofinvasive cancers
involves the loss of cell adhesion, one would predict that
an increased eﬃcacy of radiation therapy to block invasive
tubulogenesis may be possible using lower doses and lower
fractions of radiation therapy than is currently prescribed.
As stated above, such an approach may prove more eﬀective
and potentially reduce damage to surrounding tissue.
3.Summary
The tubulogenesis model proposes that primary carcinomas
of the prostate invade by a budding process similar to
embryonic tubulogenesis. The majority of tumors arise from
HGPIN lesions with the invasion occurring in portions of
the gland where basal cells are lost, and the basal lamina
is altered. If the tubulogenesis is complete, well-polarized
tubules are formed which are recognized as low Gleason
grade carcinoma; partial failure of polarity and lumen
formation results in cribiform lesions; complete failure leads
to the solid trabecular formations of Gleason grade 4 lesions.
EMT is not observed in prostate carcinoma specimens
eitherbydirect morphological assessment orbyimmunohis-
tochemical analysis of tissue using speciﬁc markers of EMT.
If the EMT process does occur in the disease, it may occur
as a late phenomenon most likely at the growing tips of the
tubular structures. Lastly, a careful molecular analysis of the
changes occurring at the tips of these tubular studies is likely
to produce important information. Understanding molecu-
lar networks at the invasive tips may become the cornerstone
of new diagnostic biomarkers to distinguish aggressive from
indolent disease and to customize therapeutic treatments for
preventing prostate carcinoma spread.
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